Maria Bordukova, Alina J Arneth, Nikita Makarov, Robyn M Brown, Elena K Schneider-Futschik, Shyamali C Dharmage, Elif Ekinci, Peter J Crack, Danny M Hatters, Alastair G Stewart, David Stroud, Teresa Sadras, Gary P Anderson, Fabian Schmich, Raul Rodriguez-Esteban, Michael P Menden
{"title":"生成式人工智能和数字双胞胎:塑造从精准医疗到真正个性化医疗的范式转变。","authors":"Maria Bordukova, Alina J Arneth, Nikita Makarov, Robyn M Brown, Elena K Schneider-Futschik, Shyamali C Dharmage, Elif Ekinci, Peter J Crack, Danny M Hatters, Alastair G Stewart, David Stroud, Teresa Sadras, Gary P Anderson, Fabian Schmich, Raul Rodriguez-Esteban, Michael P Menden","doi":"10.1080/17460441.2025.2507376","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12267,"journal":{"name":"Expert Opinion on Drug Discovery","volume":" ","pages":"821-826"},"PeriodicalIF":6.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine.\",\"authors\":\"Maria Bordukova, Alina J Arneth, Nikita Makarov, Robyn M Brown, Elena K Schneider-Futschik, Shyamali C Dharmage, Elif Ekinci, Peter J Crack, Danny M Hatters, Alastair G Stewart, David Stroud, Teresa Sadras, Gary P Anderson, Fabian Schmich, Raul Rodriguez-Esteban, Michael P Menden\",\"doi\":\"10.1080/17460441.2025.2507376\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12267,\"journal\":{\"name\":\"Expert Opinion on Drug Discovery\",\"volume\":\" \",\"pages\":\"821-826\"},\"PeriodicalIF\":6.0000,\"publicationDate\":\"2025-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Opinion on Drug Discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17460441.2025.2507376\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17460441.2025.2507376","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/23 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
期刊介绍:
Expert Opinion on Drug Discovery (ISSN 1746-0441 [print], 1746-045X [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on novel technologies involved in the drug discovery process, leading to new leads and reduced attrition rates. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.
The Editors welcome:
Reviews covering chemoinformatics; bioinformatics; assay development; novel screening technologies; in vitro/in vivo models; structure-based drug design; systems biology
Drug Case Histories examining the steps involved in the preclinical and clinical development of a particular drug
The audience consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and other closely related professionals looking to enhance the success of their drug candidates through optimisation at the preclinical level.